Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. - Yoneda ,T.; Sasaki ,A.; Dunstan ,C.; Williams ,P.J.; Bauss ,F.; De Clerck ,Y.A. (J Clin Invest, 1997)